We examined the effect of Cant on the production of MMPs by RA-FLS cells using Western blot and found that pre-treatment with Cant markedly suppressed the protein expression of MMP1 and MMP3, but not MMP2 (Figure 2H–K). The gene discussed is MMP3; the disease is rheumatoid arthritis.